View in EDS HTML Full Text PDF Full Text

General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy.

Saved in:
Bibliographic Details
Title: General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy.
Authors: Li Z; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Mirams GR; Centre for Mathematical Medicine & Biology, School of Mathematical Sciences, University of Nottingham, Nottingham, UK., Yoshinaga T; Global Cardiovascular Assessment, Eisai Co., Ltd., Tokyo, Japan., Ridder BJ; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Han X; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Chen JE; Division of Biometrics VI, Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Stockbridge NL; Division of Cardiovascular and Renal Products, Office of Drug Evaluation I, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Wisialowski TA; Global Safety Pharmacology, Pfizer, Inc., Groton, Connecticut, USA., Damiano B; Global Safety Pharmacology/Nonclinical Safety, Janssen Research & Development, Raritan, New Jersey, USA., Severi S; Department of Electrical, Electronic, and Information Engineering, University of Bologna, Cesena, Italy., Morissette P; Department of Safety Assessment and Laboratory Animal Resources, Merck & Co., Kenilworth, New Jersey, USA., Kowey PR; Main Line Health and Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA., Holbrook M; Certara, Ltd., Sheffield, UK., Smith G; Clyde Biosciences Ltd, Glasgow, UK.; Institute of Cardiovascular and Medical Sciences, Glasgow University, Glasgow, UK., Rasmusson RL; Department of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA., Liu M; Division of Cardiology, Department of Medicine, University of California, Los Angeles, Los Angeles, California, USA., Song Z; Division of Cardiology, Department of Medicine, University of California, Los Angeles, Los Angeles, California, USA., Qu Z; Division of Cardiology, Department of Medicine, University of California, Los Angeles, Los Angeles, California, USA., Leishman DJ; Department of Toxicology and Pathology, Eli Lilly and Company, Indianapolis, Indiana, USA., Steidl-Nichols J; Covance Inc., Madison, Wisconsin, USA., Rodriguez B; Department of Computer Science, University of Oxford, Oxford, UK., Bueno-Orovio A; Department of Pharmacology, University of California Davis, Davis, California, USA., Zhou X; Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia., Passini E; Department of Computer Science, University of Oxford, Oxford, UK., Edwards AG; Department of Pharmacology, University of California Davis, Davis, California, USA., Morotti S; Department of Pharmacology, University of California Davis, Davis, California, USA., Ni H; Department of Pharmacology, University of California Davis, Davis, California, USA., Grandi E; Department of Pharmacology, University of California Davis, Davis, California, USA., Clancy CE; Department of Pharmacology, University of California Davis, Davis, California, USA., Vandenberg J; Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.; St Vincent's Clinical School, UNSW Sydney, Darlinghurst, New South Wales, Australia., Hill A; Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.; St Vincent's Clinical School, UNSW Sydney, Darlinghurst, New South Wales, Australia., Nakamura M; Clinical Pharmacology Department, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan., Singer T; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Polonchuk L; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Greiter-Wilke A; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Wang K; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Nave S; Roche Product Development, Safety Science/Licensing & Early Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland., Fullerton A; Department of Safety Assessment, Genentech, Inc., South San Francisco, California, USA., Sobie EA; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Paci M; BioMediTech, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland., Musuamba Tshinanu F; Federal Agency for Medicines and Health Products, Brussels, Belgium.; European Medicines Agency, Amsterdam, The Netherlands., Strauss DG; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Jan; Vol. 107 (1), pp. 102-111. Date of Electronic Publication: 2019 Nov 10.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31709525
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Li+Z%22">Li Z</searchLink>; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Mirams+GR%22">Mirams GR</searchLink>; Centre for Mathematical Medicine & Biology, School of Mathematical Sciences, University of Nottingham, Nottingham, UK.<br /><searchLink fieldCode="AU" term="%22Yoshinaga+T%22">Yoshinaga T</searchLink>; Global Cardiovascular Assessment, Eisai Co., Ltd., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ridder+BJ%22">Ridder BJ</searchLink>; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Han+X%22">Han X</searchLink>; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Chen+JE%22">Chen JE</searchLink>; Division of Biometrics VI, Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Stockbridge+NL%22">Stockbridge NL</searchLink>; Division of Cardiovascular and Renal Products, Office of Drug Evaluation I, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Wisialowski+TA%22">Wisialowski TA</searchLink>; Global Safety Pharmacology, Pfizer, Inc., Groton, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Damiano+B%22">Damiano B</searchLink>; Global Safety Pharmacology/Nonclinical Safety, Janssen Research & Development, Raritan, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Severi+S%22">Severi S</searchLink>; Department of Electrical, Electronic, and Information Engineering, University of Bologna, Cesena, Italy.<br /><searchLink fieldCode="AU" term="%22Morissette+P%22">Morissette P</searchLink>; Department of Safety Assessment and Laboratory Animal Resources, Merck & Co., Kenilworth, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Kowey+PR%22">Kowey PR</searchLink>; Main Line Health and Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Holbrook+M%22">Holbrook M</searchLink>; Certara, Ltd., Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Smith+G%22">Smith G</searchLink>; Clyde Biosciences Ltd, Glasgow, UK.; Institute of Cardiovascular and Medical Sciences, Glasgow University, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Rasmusson+RL%22">Rasmusson RL</searchLink>; Department of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA.<br /><searchLink fieldCode="AU" term="%22Liu+M%22">Liu M</searchLink>; Division of Cardiology, Department of Medicine, University of California, Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Song+Z%22">Song Z</searchLink>; Division of Cardiology, Department of Medicine, University of California, Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Qu+Z%22">Qu Z</searchLink>; Division of Cardiology, Department of Medicine, University of California, Los Angeles, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Leishman+DJ%22">Leishman DJ</searchLink>; Department of Toxicology and Pathology, Eli Lilly and Company, Indianapolis, Indiana, USA.<br /><searchLink fieldCode="AU" term="%22Steidl-Nichols+J%22">Steidl-Nichols J</searchLink>; Covance Inc., Madison, Wisconsin, USA.<br /><searchLink fieldCode="AU" term="%22Rodriguez+B%22">Rodriguez B</searchLink>; Department of Computer Science, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Bueno-Orovio+A%22">Bueno-Orovio A</searchLink>; Department of Pharmacology, University of California Davis, Davis, California, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+X%22">Zhou X</searchLink>; Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Passini+E%22">Passini E</searchLink>; Department of Computer Science, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Edwards+AG%22">Edwards AG</searchLink>; Department of Pharmacology, University of California Davis, Davis, California, USA.<br /><searchLink fieldCode="AU" term="%22Morotti+S%22">Morotti S</searchLink>; Department of Pharmacology, University of California Davis, Davis, California, USA.<br /><searchLink fieldCode="AU" term="%22Ni+H%22">Ni H</searchLink>; Department of Pharmacology, University of California Davis, Davis, California, USA.<br /><searchLink fieldCode="AU" term="%22Grandi+E%22">Grandi E</searchLink>; Department of Pharmacology, University of California Davis, Davis, California, USA.<br /><searchLink fieldCode="AU" term="%22Clancy+CE%22">Clancy CE</searchLink>; Department of Pharmacology, University of California Davis, Davis, California, USA.<br /><searchLink fieldCode="AU" term="%22Vandenberg+J%22">Vandenberg J</searchLink>; Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.; St Vincent's Clinical School, UNSW Sydney, Darlinghurst, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Hill+A%22">Hill A</searchLink>; Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia.; St Vincent's Clinical School, UNSW Sydney, Darlinghurst, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Nakamura+M%22">Nakamura M</searchLink>; Clinical Pharmacology Department, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Singer+T%22">Singer T</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Polonchuk+L%22">Polonchuk L</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Greiter-Wilke+A%22">Greiter-Wilke A</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wang+K%22">Wang K</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Nave+S%22">Nave S</searchLink>; Roche Product Development, Safety Science/Licensing & Early Development, F. Hoffmann-La Roche Ltd., Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fullerton+A%22">Fullerton A</searchLink>; Department of Safety Assessment, Genentech, Inc., South San Francisco, California, USA.<br /><searchLink fieldCode="AU" term="%22Sobie+EA%22">Sobie EA</searchLink>; Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Paci+M%22">Paci M</searchLink>; BioMediTech, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.<br /><searchLink fieldCode="AU" term="%22Musuamba+Tshinanu+F%22">Musuamba Tshinanu F</searchLink>; Federal Agency for Medicines and Health Products, Brussels, Belgium.; European Medicines Agency, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Strauss+DG%22">Strauss DG</searchLink>; Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2020 Jan; Vol. 107 (1), pp. 102-111. <i>Date of Electronic Publication: </i>2019 Nov 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31709525
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cpt.1647
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 102
    Titles:
      – TitleFull: General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Li Z
      – PersonEntity:
          Name:
            NameFull: Mirams GR
      – PersonEntity:
          Name:
            NameFull: Yoshinaga T
      – PersonEntity:
          Name:
            NameFull: Ridder BJ
      – PersonEntity:
          Name:
            NameFull: Han X
      – PersonEntity:
          Name:
            NameFull: Chen JE
      – PersonEntity:
          Name:
            NameFull: Stockbridge NL
      – PersonEntity:
          Name:
            NameFull: Wisialowski TA
      – PersonEntity:
          Name:
            NameFull: Damiano B
      – PersonEntity:
          Name:
            NameFull: Severi S
      – PersonEntity:
          Name:
            NameFull: Morissette P
      – PersonEntity:
          Name:
            NameFull: Kowey PR
      – PersonEntity:
          Name:
            NameFull: Holbrook M
      – PersonEntity:
          Name:
            NameFull: Smith G
      – PersonEntity:
          Name:
            NameFull: Rasmusson RL
      – PersonEntity:
          Name:
            NameFull: Liu M
      – PersonEntity:
          Name:
            NameFull: Song Z
      – PersonEntity:
          Name:
            NameFull: Qu Z
      – PersonEntity:
          Name:
            NameFull: Leishman DJ
      – PersonEntity:
          Name:
            NameFull: Steidl-Nichols J
      – PersonEntity:
          Name:
            NameFull: Rodriguez B
      – PersonEntity:
          Name:
            NameFull: Bueno-Orovio A
      – PersonEntity:
          Name:
            NameFull: Zhou X
      – PersonEntity:
          Name:
            NameFull: Passini E
      – PersonEntity:
          Name:
            NameFull: Edwards AG
      – PersonEntity:
          Name:
            NameFull: Morotti S
      – PersonEntity:
          Name:
            NameFull: Ni H
      – PersonEntity:
          Name:
            NameFull: Grandi E
      – PersonEntity:
          Name:
            NameFull: Clancy CE
      – PersonEntity:
          Name:
            NameFull: Vandenberg J
      – PersonEntity:
          Name:
            NameFull: Hill A
      – PersonEntity:
          Name:
            NameFull: Nakamura M
      – PersonEntity:
          Name:
            NameFull: Singer T
      – PersonEntity:
          Name:
            NameFull: Polonchuk L
      – PersonEntity:
          Name:
            NameFull: Greiter-Wilke A
      – PersonEntity:
          Name:
            NameFull: Wang K
      – PersonEntity:
          Name:
            NameFull: Nave S
      – PersonEntity:
          Name:
            NameFull: Fullerton A
      – PersonEntity:
          Name:
            NameFull: Sobie EA
      – PersonEntity:
          Name:
            NameFull: Paci M
      – PersonEntity:
          Name:
            NameFull: Musuamba Tshinanu F
      – PersonEntity:
          Name:
            NameFull: Strauss DG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2020 Jan
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1532-6535
          Numbering:
            – Type: volume
              Value: 107
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical pharmacology and therapeutics
              Type: main
ResultId 1